FIRST: President of India unveils India's home-grown gene therapy for cancer

The President was happy to note that the therapy being launched is the world's most affordable CAR-T cell therapy.

Written By :  Ruchika Sharma
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2024-04-05 06:00 GMT   |   Update On 2024-04-05 06:00 GMT

New Delhi: The President of India, Smt Droupadi Murmu has launched India’s first home-grown gene therapy for cancer at IIT Bombay.Speaking on the occasion, the President said that the launch of India’s first gene therapy is a major breakthrough in our battle against cancer. As this line of treatment, named “CAR-T cell therapy”, is accessible and affordable, it provides a new hope for...

Login or Register to read the full article

New Delhi: The President of India, Smt Droupadi Murmu has launched India’s first home-grown gene therapy for cancer at IIT Bombay.

Speaking on the occasion, the President said that the launch of India’s first gene therapy is a major breakthrough in our battle against cancer. As this line of treatment, named “CAR-T cell therapy”, is accessible and affordable, it provides a new hope for the whole of humankind. She expressed confidence that it will be successful in giving new lives to countless patients.

The President said that CAR-T cell therapy is considered to be one of the most phenomenal advances in medical science. It has been available in the developed nations for some time, but it is extremely costly, and beyond the reach of most patients around the world. She was happy to note that the therapy being launched is the world’s most affordable CAR-T cell therapy. She said that it is also an example of the ‘Make in India’ initiative; a shining example of the ‘Atmanirbhar Bharat’.

The President was happy to note that India’s first CAR-T cell therapy is developed through collaboration between the Indian Institute of Technology, Bombay and Tata Memorial Hospital in association with industry partner ImmunoACT. She said that this is a praiseworthy example of academia-industry partnership, which should inspire many more similar efforts.

The President said that IIT Bombay is renowned, not only in India but across the world, as a model of technology education. In the development of CAR-T cell therapy, technology is not only being put in the service of humanity, but partnerships have been with an eminent institution from another field as well as with industry. This has been made possible by the focus IIT, Bombay has placed on research and development over the last three decades. She said that with the knowledge base and skills of the faculty and students of IIT Bombay and other similar institutions, India as a whole, would benefit greatly from the technological revolution underway.

Read also: India leads first human clinical trial of gene therapy for haemophilia A: Dr Jitendra Singh

Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News